Financials
Financial year 2025
Worth noting
- Figures corrected afterwards (2025).
Gross margin
€ 3.3 million
▲ 1% vs 2024
Profit
Healthy€ 2.2 million
▼ 3% vs 2024
Debts
High€ 10.8 million
▲ 576% vs 2024
GLOBIFER INTL from Kontich, company number BE0843493885, closed financial year 2025 with a result of € 2.2 million after tax. For that financial year GLOBIFER INTL recorded a gross margin of € 3.3 million and equity of € 289,440. Compared with financial year 2024, the result moved from € 2.3 million to € 2.2 million. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
What happened at GLOBIFER INTL?
What happened at GLOBIFER INTL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2025. Source: NBB ↗
- Aquitania BV became a director. NBB
- A-Pop Management COMMV became a director. NBB
- MD Consult BV became a director. NBB
- New establishment in Kontich. KBO
- Start of the company according to the CBE. KBO
In short
From € 1.1 million profit in 2021 to € 2.2 million profit in 2025.
Paid € 3.3 million in corporate taxes since 2021.
Best year ever: 2024, with € 2.3 million profit.
On average € 1.6 million of value added per employee in 2022.
A new publication or filing at GLOBIFER INTL? We notify you, reason included.
Follow GLOBIFER INTLNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind GLOBIFER INTL are Aquitania BV, A-Pop Management COMMV and MD Consult BV. The same people are also behind Ceres Pharmaceuticals, VESALE PHARMACEUTICA, b+pharma Belgium, DGPharma and Labophar.
Directors
According to the 2025 annual accounts
Chairman of the board · represented by Anja Imschoot
Also active at: Ceres Pharmaceuticals, VESALE PHARMACEUTICA, b+pharma Belgium +6 more
since 2021
Managing director · represented by Anthony Popowski
Also active at: PHARMACEUTICAL ENTERPRISES BELGIUM, GLOBIPHARM
since 2021
Director · represented by Mario Debel
Also active at: Ceres Pharmaceuticals, VESALE PHARMACEUTICA, 2PHARMA HOLDING +5 more
since 2021
Establishments
Establishment units
Physical locations of this company
Satenrozen 6A box 2
2550 Kontich
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
PHARMACEUTICAL ENTERPRISES BELGIUM same network
€ 53,524 gross margin · 2025
CADIS
€ 986,725 gross margin · 2025
Straalstudio
Schilderstudio
€ 887,895 gross margin · 2025
BJ BTW EENHEID
+8 more
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Self-hosted
Hosting
DIGITALOCEAN-ASN - DigitalOcean, LLC, US
Domain
Domain
globifer.eu
Registrar
Combell NV
Website info
Features
Security
Details
- Company number
- 0843.493.885
- VAT number
- BE 0843.493.885
- Registered office
- Satenrozen 6A bus 2, 2550 Kontich
- Names & denominations
- GLOBIFER INTL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 February 2012
- Peppol
- Active · Active since 27 Mar 2026
- Contact
- globifer.eu
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Handelsbemiddeling in de groothandel in voedings- en genotmiddelen